Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
| $9.16M | ﹤0.01% |
27,545
-466,919
| -94% | -$155M |
|
1202
Lennox International
LII
$14.4B
| $9.15M | ﹤0.01% |
36,432
+1,503
| +4% | +$379K |
|
1203
PUT
Marriott International
MAR
$98.3B
| $9.13M | ﹤0.01% |
55,000
-30,000
| -35% | -$5M |
|
1204
CALL
Alnylam Pharmaceuticals
ALNY
$27.5B
| $9.09M | ﹤0.01% |
45,400
-28,100
| -38% | -$5.91M |
|
|
GTLS
1205
DELISTED
Chart Industries
GTLS
| $9.06M | ﹤0.01% |
72,264
+28,799
| +66% | +$3.71M |
|
|
GAP
1206
The Gap Inc
GAP
$7.23B
| $9.05M | ﹤0.01% |
901,106
-367,741
| -29% | -$4.48M |
|
1207
Helen of Troy
HELE
$644M
| $8.99M | ﹤0.01% |
94,476
+86,366
| +1,065% | +$9.24M |
|
1208
STAAR Surgical
STAA
$1.21B
| $8.99M | ﹤0.01% |
140,501
+34,400
| +32% | +$2.25M |
|
|
NKLA
1209
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $8.97M | ﹤0.01% |
247,213
+58,666
| +31% | +$3.85M |
|
1210
CALL
Wells Fargo
WFC
$261B
| $8.97M | ﹤0.01% |
240,000
-2,364,500
| -91% | -$103M |
|
|
RVNC
1211
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.95M | ﹤0.01% |
277,935
-30,629
| -10% | -$955K |
|
|
PARA
1212
PUT
DELISTED
Paramount Global Class B
PARA
| $8.92M | ﹤0.01% |
400,000
-1,400,000
| -78% | -$30M |
|
1213
Annaly Capital Management
NLY
$17.1B
| $8.9M | ﹤0.01% |
465,479
-6,939
| -1% | -$146K |
|
1214
Teladoc Health
TDOC
$1.22B
| $8.89M | ﹤0.01% |
343,163
-262,932
| -43% | -$7.04M |
|
|
AMYT
1215
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $8.89M | ﹤0.01% |
+609,546
| New | +$8.61M |
|
1216
CALL
MGM Resorts International
MGM
$11.4B
| $8.88M | ﹤0.01% |
200,000
-20,000
| -9% | -$831K |
|
1217
Henry Schein
HSIC
$9.77B
| $8.87M | ﹤0.01% |
108,777
-66,079
| -38% | -$5.38M |
|
1218
ZTO Express
ZTO
$18.3B
| $8.83M | ﹤0.01% |
308,124
-387,328
| -56% | -$10.6M |
|
1219
Cleveland-Cliffs
CLF
$6.57B
| $8.82M | ﹤0.01% |
481,038
-64,544
| -12% | -$1.28M |
|
1220
Middleby
MIDD
$6.04B
| $8.78M | ﹤0.01% |
59,915
+4,686
| +8% | +$696K |
|
1221
Universal Health Services
UHS
$10.2B
| $8.77M | ﹤0.01% |
68,998
-111,218
| -62% | -$15.3M |
|
1222
Northern Oil and Gas
NOG
$2.3B
| $8.76M | ﹤0.01% |
288,752
+64,161
| +29% | +$2M |
|
1223
PUT
Marathon Digital Holdings
MARA
$4.32B
| $8.72M | ﹤0.01% |
+1,000,000
| New | +$6.98M |
|
|
APTV.PRA
1224
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
| $8.69M | ﹤0.01% |
70,775
-19,453
| -22% | -$2.38M |
|
1225
Paylocity
PCTY
$7.38B
| $8.68M | ﹤0.01% |
43,672
-2,000
| -4% | -$394K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.